Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apria, Inc. stock logo
APR
Apria
$37.50
$37.45
$22.36
$40.00
$1.34BN/A682,285 shsN/A
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$102.43
+1.7%
$106.75
$72.21
$139.13
$5.04B0.48675,968 shs181,810 shs
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$31.05
-1.5%
$32.08
$21.39
$35.53
$5.08B0.741.88 million shs801,117 shs
Teleflex Incorporated stock logo
TFX
Teleflex
$116.74
-1.3%
$125.44
$115.99
$249.91
$5.15B1.1627,830 shs93,170 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apria, Inc. stock logo
APR
Apria
0.00%0.00%0.00%0.00%0.00%
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
0.00%-3.28%-4.17%-22.05%+31.81%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.00%-0.22%+0.38%-9.16%+11.89%
Teleflex Incorporated stock logo
TFX
Teleflex
0.00%-1.58%-2.41%-16.66%-41.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apria, Inc. stock logo
APR
Apria
N/AN/AN/AN/AN/AN/AN/AN/A
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
4.7127 of 5 stars
4.52.00.04.52.04.20.6
Option Care Health, Inc. stock logo
OPCH
Option Care Health
3.9576 of 5 stars
2.43.00.04.23.11.71.3
Teleflex Incorporated stock logo
TFX
Teleflex
4.6094 of 5 stars
3.04.02.53.92.81.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apria, Inc. stock logo
APR
Apria
0.00
N/AN/AN/A
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
3.06
Buy$172.3368.25% Upside
Option Care Health, Inc. stock logo
OPCH
Option Care Health
2.88
Moderate Buy$35.5014.33% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.09
Hold$164.6341.02% Upside

Current Analyst Ratings Breakdown

Latest APR, TFX, OPCH, and AXSM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/18/2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$36.00
6/12/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$193.00 ➝ $186.00
6/10/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$180.00
6/9/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$153.00 ➝ $150.00
6/3/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$185.00
5/22/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$180.00 ➝ $180.00
5/14/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/7/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$200.00 ➝ $180.00
5/6/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00 ➝ $165.00
5/6/2025
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$160.00 ➝ $162.00
5/5/2025
Teleflex Incorporated stock logo
TFX
Teleflex
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$140.00 ➝ $137.00
(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apria, Inc. stock logo
APR
Apria
$1.15B1.17$5.27 per share7.12$1.12 per share33.48
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$385.69M13.08N/AN/A$1.18 per share86.80
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$5.00B1.02$1.62 per share19.17$8.25 per share3.76
Teleflex Incorporated stock logo
TFX
Teleflex
$3.05B1.69$25.05 per share4.66$92.11 per share1.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apria, Inc. stock logo
APR
Apria
$64.88MN/A0.0020.49N/A5.66%586.18%9.23%N/A
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
-$287.22M-$5.77N/A36.32N/A-64.39%-272.80%-36.69%8/4/2025 (Estimated)
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$211.82M$1.2425.0124.641.904.12%16.90%7.00%7/30/2025 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
$69.68M$3.1736.787.691.854.96%14.73%8.79%7/30/2025 (Estimated)

Latest APR, TFX, OPCH, and AXSM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
Teleflex Incorporated stock logo
TFX
Teleflex
$2.88$2.91+$0.03$2.07$699.37 million$700.67 million
4/29/2025Q1 2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apria, Inc. stock logo
APR
Apria
N/AN/AN/AN/AN/A
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
N/AN/AN/AN/AN/A
Option Care Health, Inc. stock logo
OPCH
Option Care Health
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.361.16%N/A42.90%N/A

Latest APR, TFX, OPCH, and AXSM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/12/2025
Teleflex Incorporated stock logo
TFX
Teleflex
quarterly$0.341.09%5/20/20255/20/20256/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apria, Inc. stock logo
APR
Apria
8.58
1.09
1.06
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
3.48
2.03
1.96
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.82
1.54
1.02
Teleflex Incorporated stock logo
TFX
Teleflex
0.44
2.28
1.32

Institutional Ownership

CompanyInstitutional Ownership
Apria, Inc. stock logo
APR
Apria
N/A
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
81.49%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
98.05%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%

Insider Ownership

CompanyInsider Ownership
Apria, Inc. stock logo
APR
Apria
N/A
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
22.40%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.64%
Teleflex Incorporated stock logo
TFX
Teleflex
1.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Apria, Inc. stock logo
APR
Apria
6,08035.65 millionN/ANot Optionable
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
38049.24 million38.21 millionOptionable
Option Care Health, Inc. stock logo
OPCH
Option Care Health
8,088163.75 million162.70 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
14,10044.19 million43.57 millionOptionable

Recent News About These Companies

Teleflex Incorporated stock logo
Teleflex (NYSE:TFX) Reaches New 1-Year Low - What's Next?
Teleflex (NYSE:TFX) Upgraded to "Buy" at Wall Street Zen
Brokerages Set Teleflex Incorporated (NYSE:TFX) PT at $164.63
Teleflex Incorporated stock logo
Wall Street Zen Upgrades Teleflex (NYSE:TFX) to "Buy"
Teleflex has positive Arrow catheter data

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Apria stock logo

Apria NYSE:APR

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc.

Axsome Therapeutics stock logo

Axsome Therapeutics NASDAQ:AXSM

$102.42 +1.73 (+1.72%)
As of 01:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial for treating attention-deficit/hyperactivity disorder, and is in phase 2 major depressive, binge eating, and shift work disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Option Care Health stock logo

Option Care Health NASDAQ:OPCH

$31.04 -0.49 (-1.54%)
As of 01:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Teleflex stock logo

Teleflex NYSE:TFX

$116.74 -1.57 (-1.33%)
As of 01:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.